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Background: Tardive dystonia (TD) represents a side effect of prolonged intake of dopamine
receptor blocking compounds. TD can be a disabling movement disorder persisting despite
available medical treatment. Deep brain stimulation (DBS) has been reported successful in
this condition although the number of treated patients with TD is still limited to small
clinical studies or case reports. The aim of this study was to present the systematical
overview of the existing literature regarding DBS for intractable TD.
Methods and results: A literature search was carried out in PudMed. Clinical case series or case
reports describing the patients with TD after DBS treatment were included in the present
overview. Literature search revealed 19 articles reporting 59 individuals operated for TD. GPi
was the target in 55 patients, while subthalamic nucleus (STN) was the target in the
remaining 4. In most studies the motor part of Burke–Fahn–Marsden Dystonia Rating Scale
(BFMDRS) was improved by more than 80% when compared to preoperative BFMDRS scores.
Conclusions: The performed literature analysis indicates that bilateral GPi DBS is an effective
treatment for disabling TD. The response of TD to bilateral GPi DBS may be very rapid and
occurs within days/weeks after the procedure. The efﬁcacy of bilateral GPi DBS in TD patients
is comparable to results achieved in patients with primary generalized dystonia.
# 2016 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Chronic intake of dopamine receptor blocking compounds
may have as a consequence the development of tardive
movement disorders including tardive dyskinesia and
tardive dystonia (TD) [1]. Both tardive movement disorders
cause emotional and social distress but TD develops faster,
is more painful, distressing and disabling than tardive
dyskinesia [1]. TD usually does not differ from focal,* Corresponding author at: 8 Kondratowicza Street, 03-242, Warsaw, P
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0028-3843/# 2016 Polish Neurological Society. Published by Elsevier Ssegmental or generalized primary dystonia. In two-thirds
of all cases TD affects cervical muscles. TD treatment
consists of gradual withdrawal of provoking medications
and substitution of atypical neuroleptics such as clozapine
or administration of tetrabenazine, dopamine agonists, and
anticholinergic drugs [1]. In some cases pharmacological
treatment of TD may be challenging and ineffective. Clinical
similarity between TD and primary dystonia has paved the
way for its neurosurgical treatment – nowadays mainly with
pallidal DBS [2].oland. Tel.: +48 22 32 65 779; fax: +48 22 326 589.
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refractory primary generalized, segmental or even focal
dystonia [2,3]. The experience of the efﬁcacy and safety proﬁle
using pallidal DBS in TD patients is far less studied. The
reasons for it may be the following facts. Patients diagnosed
with secondary dystonia (such as hemidystonia or dystonia
associated with cerebral palsy) fare less well after pallidal DBS
than patients with primary generalized dystonia [4]. Psychiat-
ric co-morbidity is considered a contraindication for DBS
surgery by many investigators. These two main reasons may
explain why the experience of DBS surgery in TD remains
limited to small studies or case series [5–14]. Therefore, the
main aim of this overview was to present a systematic
literature review dealing with DBS for TD. We have performed
the detailed discussion on the outcomes, stimulation settings,
and surgical complications as well the safety proﬁle of bilateral
pallidal stimulation in TD patients. Moreover the possible
underlying effects of DBS for TD using functional imaging
studies have been discussed.
2. Clinical characteristics of tardive dystonia
patients treated by deep brain stimulation
Since 2001, we have identiﬁed 9 original articles, in which a
total of 38 patients diagnosed with TD underwent DBS
procedures [5–13]. Moreover, since 2003 in another 10
published articles reporting a total of 198 patients with various
types of primary or secondary dystonia we have found
additional 21 patients harboring neuroleptic-induced or
drug-induced TD [3,15–23]. To our knowledge, a total of 59
patients with TD have been described in literature. In 10
articles that present the series for various types of dystonia
some data regarding patients' sex, disease duration, and
clinical outcome are often presented as a cumulative outcome
for all dystonia patients regardless of dystonia type, which
considerably handicaps the clinical analysis of patient data.
Nevertheless, among 59 patients there were 27 females and 20
males; in the remaining 12 individuals the patient's gender
could not be identiﬁed. The mean TD duration from diagnosis
to surgery was 5.5 years ranging 0.5–23 years. The mean age at
surgery was 50.2 years ranging from 28 to 76 years.
In the 9 articles reporting the outcome only for TD patients
the psychiatric indication for using neuroleptic drugs was
stated. To the contrary, none of the 10 articles reporting the
outcome for various dystonic conditions presented the
underlying psychiatric indication. Among known psychiatric
indications, neuroleptics subsequently developing TD were
used to treat depression in 19 patients, schizophrenia in
5 patients, and in the remaining 11 patients various psychiatric
disorders including bipolar disorder, psychosis, or anxiety
disorder. Interestingly, out of a total of 59 patients, only
3 patients developed TD after prolonged antiemetic treatment
in which metoclopramid was administered to treat gastritis
[10,13,17]. In the remaining 56 patients TD developed as a
consequence of neuroleptics. The most common identiﬁable
neuroleptic was haloperidol found in 15 patients as a causative
drug for inducing TD. In general, in 42 patients speciﬁc
neuroleptics were identiﬁed, whereas in the remaining
14 patients no neuroleptic drug was named. The exact timeof the neuroleptic exposure was provided in 23 patients and
the mean time from neuroleptic exposure to TD development
was 43.9 months ranging from 3 to 300 months.
Most individuals (53 patients) underwent bilateral GPi DBS
[5–13,15–23]. Moreover, in 2 additional patients unilateral GPi
DBS was performed to treat TD 13. In only 4 patients bilateral
STN DBS was undertaken [17,18]. In 1 patient two targets GPi
and ventral intermediate thalamic nucleus (Vim) were
approached [5]. The mean postoperative follow-up period
was 29 months ranging from 3 to 80 months.
3. Clinical outcome of pallidal deep brain
stimulation for tardive dystonia
DBS for TD was ﬁrst reported by Trottenberg et al. and
revealed a high efﬁcacy of bilateral GPi stimulation in a
70-year-old patient with TD decreasing the total BFMRDS
scores by 73%, whereas thalamic Vim stimulation had no
effect on dystonic symptoms [5]. The same study group
presented additional results in 5 consecutive TD patients
decreasing the BFMDRS motor and disability scores by 83%
and 94% respectively, 6 months postoperatively [6]. Gruber
et al. presented the largest series to date, featuring 9 patients
including 3 patients reported earlier by Trottenberg et al. [10].
In this study at the mean postoperative follow-up time of 40.7
 20.9 months the BFMDRS motor and disability scores
improved by 83% and 68% respectively [10]. Franzini at al.
[7] as well Cohen et al. [8] presented 2 patients in each study,
also reporting a very favorable outcome. Sako et al. [9]
operated on 6 patients with TD decreasing the BFMDRS motor
and disability scores by 86  14% and 80  12% respectively at
mean follow-up of 21  18 months. Capelle et al. [11] included
2 patients with craniocervical TD and 2 patients with
generalized TD. At the last follow-up of 27.3 months the
BFMDRS motor and disability scores improved by 77% and 84%
respectively. In the last study reported by Chang et al. [12] the
BFMDRS motor and disability scores improved by 71% and 48%
respectively at the last follow-up ranging from 24 to 96
months. In the recent published study by Shaikh et al.
8 patients with TD were included. The total motor BFMDRS
scores were improved by 85.1  13.5% at the last follow-up
ranging from 12 to 60 months. The outcomes of all 9 articles
are summarized in Table 1 in a chronological order, by
objective results based on BFMDRS scores after bilateral
pallidal DBS. Some authors used additionally Abnormal
Involuntary Movement Scale (AIMS) or Extrapyramidal
Symptoms Rating Scale (ESRS) which may suggest that not
all patients included in the study suffered from Type I – Pure
Tardive Dystonia according to the recommendations provid-
ed by Adityanjee et al. [1]. Some of these patients may have
exhibited Type II Tardive Dystonia with coexisting dyskinetic
movements in the same or a different body part, but dystonia
was the most prominent manifestation. In the study by
Trottenberg et al. [6], Gruber et al. [10], and Chang et al. [12],
the above-mentioned scales like AIMS or ESRS were used in
addition to the BFMDRS scores in order to rate coexisting
dyskinetic movements.
In the remaining 10 articles reporting series with various
types of dystonia, in 2 articles the STN was the target to treat
Table 1 – Published articles presented in chronological order reporting the results of bilateral GPi DBS for patients treated for
TD. 38 patients are reported in 9 articles. AIMS, Abnormal Involuntary Movement Scale; ERSR, Extrapyramidal Symptoms
Rating Scale; pt, patient; pts, patients; mo, months; FU, follow-up; TD, tardive dytonia; NR, not reported.
Authors and
publication
years
Number of
patients
Disease
duration
(years)
Type of DT BFMDRS Scale
Motor/disability
Subscale
FU Time
(mo)
Last FU Score
BFMDRS Scale
Motor/disability
Subscale
Percentage
improvement
of BFMDRS
Trottenberg et al.
[5] 2001
1 6 Multifocal BFMDRS m
34.5/
AIMS
24
6 9.5
11
73%
54%
Trottenberg et al.
[6]2005
5 NR NR BFMDRS m/d 32/8 6 NR 83%/94%
Franzini et al.
[7] 2005
Pt 1 5 Generalized BFMDRS t
36
12 5 42%
Pt 2 3 Generalized BFMDRS t
70
12 8 78%
Cohen et al.
[8] 2007
Pt 1 4 Generalized BFMDRS m/d
21.5/4
13 3/0 86%/100%
Pt 2 4 Generalized BFMDRS m/d
31.5/19
7 11.5/9 64%/53%
Sako et al.
[9] 2008
6 3.1 (0.5–6) NR
Severe TD
Individual scores
provided for each
patient
21  18 NR 86  14%/
80  12%
Gruber et al.
[10] 2009
9 NR BFMDRS m/d
30.9/11.6
AIMS
23.1
40.7  20.9
From 18 to 80
5.5/3.4
4.3
83%/67.7%
78.7%
Capelle et al.
[11] 2010
4 6.7 2 pts generalized
2 pts craniocervical
BFMDRS m/d
43/6
27.3 7/2 77%/84%
Chang et al.
[12] 2010
5 10.2 4 pts generalized
dystonia
1 pt segmental
dystonia
BFMDRS m/d
49.7/11.8
ESRS
10.5
24–96 14.5/6.2
2
71%/47.9%
77%
Shaikh et al.
[13] 2015
8 5.4  2.8 6 pts generalized
dystonia
2 pts segmental
dystonia
Individual scores
provided for each
patient
BFMDRS
m
6–60 NR 85.1  13.5%
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[20], Maraginos-Ascone et al. [21], Katsokiori et al. [22], and Kim
et al. [23] discuss a single TD patient in each study. All these
articles indicate that bilateral GPi DBS improved the BFMDRS
motor and disability scores from 28% to 77% and from 39% to
80% respectively. The largest case series among different
patients with different dystonia types was provided by Egidi
et al. [19]. These authors conclude that beside DYT-1 positive
primary dystonia group with good clinical outcome, sec-
ondary drug-induced TD had very good results in reducing
the BFMDRS motor and disability scores by 47 and 55%
respectively. Starr et al. reported 3 patients with TD who
beneﬁtted from pallidal stimulation exceeding 50% on the
total BFMDRS whereas 1 patient improved only slightly by
6% on the total BFMRDS [3]. In only 1 report by Krause at al.
[16] 3 patients with TD were unchanged after surgery.
1 patient required internal pulse generator removal one
week after surgery due to infection and was lost for follow-
up. In 2 patients steady worsening of dystonia despite
bilateral pallidal stimulation was noted. The clinical
outcome of the 10 articles reporting TD patients within
series with various dystonia types are presented in a
chronological order in Table 2.4. Clinical outcome of subthalamic deep brain
stimulation for tardive dystonia
The ﬁrst study reporting bilateral STN stimulation in 2 patients
with TD dystonia was presented by Zhang et al. [17]. These
2 patients gained beneﬁt from STN DBS in reducing their total
BFMDRS scores at last follow-up by 92% and 91%. The authors
conclude that patients with TD showed the best results among
patients with secondary dystonia types. Sun et al. presented
also their experience in using bilateral STN DBS for various
dystonic conditions [18]. Among 14 patients with various types
of dystonia, who underwent bilateral STN stimulation there
were 2 patients diagnosed with TD. Unfortunately the authors
presented aggregated results for all patients, irrespectively of
dystonia type. The mean postoperative BFMDRS scores im-
proved by 88.6% (range from 76% to 100%) at the mean follow-up
of 28.8 months. The authors argue that STN DBS has some
advantages over GPi DBS, such as immediate improvement
observed once stimulation is activated, or lower stimulation
settings needed for STN DBS. These 2 studies showed that STN
DBS had a positive effect on various dystonia types including TD
which responded favorably to STN DBS [17,18]. These studies
Table 2 – Published articles presented in chronological order reporting the results of bilateral GPi DBS for patients with
various dystonia types. 21 patients with TD are reported in 10 articles. AIMS, Abnormal Involuntary Movement Scale; ERSR,
Extrapyramidal Symptoms Rating scale; pt, patient; pts, patients; mo, months; FU, follow-up; TD, tardive dystonia; NR, not
reported.
Authors and
publication
years
Number of
patients
Disease
duration
(years)
Type of DT Scale
Subscale
FU
Time (mo)
FU Score Percentage
improvement
(%)
Yianni et al.
[15] 2003
1 among 25 pts 12 Generalized BFMDRS m/d/t
109/28/137
AIMS
24
12 78/17/95
14
28%/39%/31%
41.7%
Krause et al.
[16] 2005
3 pts
Among 17 pt 1
23 Generalized BFMDRS m
11
NR NR NR
Pt 2 5 Generalized BFMDRS m
62
30 63.5 Worsening
Pt 3 17 Generalized BFMDRS m
76
42 77.0 Worsening
Starr et al.
[3] 2006
4 pts among 23
Pt 1
7 Multifocal BFMDRS t
11
26 0 100%
Pt 2 4 Multifocal BFMDRS t
38
27 7.5 80%
Pt 3 20 Multifocal BFMDRS t
57
17 53.5 6%
Pt 4 10 Generalized BFMDRS t
80
9 37.5 63%
Zhang et al.
[17] 2006
2 pts among 9
Pt 1
3 Generalized NR 3 NA 92%
Pt 2 0.5 Multifocal NR 2 NA 91%
Sun et al.
[18] 2007
2 pts among 14
Pt 1
3 Generalized NR 28.8 for all pts NA 88.6% for all pts
Pt 2 12 Generalized NR 28.8 for all pts NA 88.6% for all pts
Egidi et al.
[19] 2007
5 pts among 69 pts 3–4 years NR BFMDSS m/d
NR
NR NR 47.2%/54.6%
Pretto et al.
[20] 2008
1 pt among 13 pts NR Generalized AIMS
19
Nearly 6 2 90%
Maraginos-
Ascone et al.
[21] 2008
1 pt among 10 4 Trunk/Focal BFMDRS m/d
46/16
AIMS
23.1
12 24/9
4.3
48%/44%
78.7%
Katsokiori et al.
[22] 2009
1 pt among 8 pts 3 Generalized BFMDRS
m/d
35/19
12 2/3 94%/98%
Kim et al.
[23] 2011
1 pt among 10 6 NR NR 20 NR 77%/80%
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conclusive evidence on which target (GPi or STN) would be
optimal for different types of dystonia including TD.
5. Onset and duration of beneﬁts after DBS
procedures for tardive dystonia
The onset of clinical beneﬁts in TD symptoms varies strongly
between reported studies or even between patients in the
same study (Tables 3 and 4). Trottenberg et al. [6] observed
clinical beneﬁts in 5 patients within 12–72 h after activation of
GPi DBS. Gruber at al. [10] in reported a rapid response within
minutes to hours after GPi DBS in 5 out a total of 9 patients,
whereas in the remaining 4 patients the improvement was
delayed to weeks or months. Most authors report that in TD
patients phasic movements respond faster than tonic postures
which subsequently improve over weeks to months. Capelle
et al. [11] observed delayed onset of improvement afteroptimization of stimulation settings. The onset of response
to GPi stimulation may be dependent on the initial stimulation
mode. Initial bipolar stimulation mode used in the study by
Capelle et al. [11] stimulates much narrower brain tissue and
therefore its onset may occur later than in monopolar
stimulation mode using adjunct contacts as cathodes with
the ventral posterolateral part of GPi. In the recent published
study by Shaikh et al. among 8 patients with TD in 4 patients
there was rapid while in 4 others the response was partial with
gradual resolution of residual dytonic symptoms over 48
months. In the study by Sun et al. [18] who used STN DBS for
TD the observed response was immediate which according to
the authors is the main advantage of STN DBS over GPi DBS in
dystonic patients. Power consumption in STN DBS is much
lower due to smaller functional target with coexisting immedi-
ate response to stimulation. This rapid response within
minutes, hours or days in TD patients reported in independent
articles is much faster than usually gradual improvement
observed in primary generalized dystonia patients.
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beneﬁt was sustained at the last follow-up. The follow-up
period varies considerably between reported studies ranging
from 3 to 96 months but the improvement is still seen even 8
years postoperatively [12]. This improvement is stable only
with an increase of stimulation voltage to maintain good
clinical outcomes. In a few studies with longer follow-ups, the
BFMDRS total scores tend to improve over the follow-up period
when compared to the ﬁrst postoperative assessment [6,12].
6. Stimulation parameters used for tardive
dystonia patients
Initial DBS parameters and initial mode of stimulation were
considerably different among the reports (Tables 5 and 6). Most
authors used the monopolar stimulation mode activating the
most ventral or two adjunct ventral contacts as cathodes
[5–9,12,13,15,21]. This type of stimulation was used by
Trottenberg et al. in 5 patients with rapid response to GPi
stimulation [6]. Other authors followed this stimulation mode
in patients with TD [9,12,13,15,21]. One exception is the study
by Capelle et al. [11] in which the initial bipolar stimulation
mode was chosen in 3 patients. The beneﬁt was delayed due to
optimization of stimulation settings and higher voltage
needed (up to 4.5 V) rarely observed in monopolar stimulation
mode. The initial bipolar stimulation mode was also used by
Yianni et al. [15] in 25 dystonic patients including 1 patient
with TD, which also necessitated higher stimulation voltage
between 4.0 and 7.0 V. Sun et al. [18] used initial bipolar mode
of stimulation with good immediate therapeutic effects but
the target was STN rather than GPi and stimulation voltage
was considerably lower, between 2.0 and 3.0 V. Generally,
authors used most ventral contacts in monopolar fashion
located in posteroventral lateral part of GPi.
Stimulation settings were highly variable among studies
depending obviously on the initial mode of stimulation.
Stimulation voltage ranged from 1.0 to 6.5 V and was regularly
monitored in most studies to achieve a stable outcome
[6,10–13,15]. Stimulation frequencies in most studies were
above 130 Hz except for the study by Kim et al. [23] where low
frequency below 100 Hz was used. Only one study used a
constant frequency of 185 Hz [22]. Stimulation pulse widths
varied between 60 ms, 90 ms, 120 ms, 210 ms or even 450 ms
[5–12]. In most studies the pulse width was adjusted during the
follow-up period to maintain good clinical outcome. The
marked individual stimulation settings used with patients in
one study or between studies may indicate that lead locations
were dissimilar in individual patients, despite the similar GPi
target. Despite these differences in stimulation settings that
may represent different lead locations all authors reported
favorable results in TD patients.
7. Safety proﬁle of deep brain stimulation
procedures in tardive dystonia patients
In a total of 59 patients after bilateral DBS procedures for TD
there were two serious complications related to the operation
[3,12]. In the study by Chang et al. [12] 1 patient developedintracerebral hemorrhage due to venous infarction which
resulted in transient hemiparesis and aphasia. This patient
recovered fully but without any mood and behavioral changes
but also without response to DBS. A similar case of multifocal
left frontal hemorrhage due to venous infarction causing
aphasia and hemiparesis with subsequent non-response to
DBS was reported by Starr et al. [3]. These 2 patients made full
recovery but remained unresponsive to DBS, since the
hemorrhage probably caused some misplacement of the
DBS lead. There were no reported deaths related to DBS
procedure in TD patients in the reviewed literature.
In the study by Capelle et al. [11] 1 patient required lead
revision due to its misplacement and 1 patient experienced
rapid IPG depletion without neurological complications. One
patient in the study by Chang et al. [12] required battery
replacement after 10 months which was complicated by a local
infection. After 2 weeks of antibiotic treatment the infection
resolved and the battery was replaced without complication.
In the study by Krause et al. [16] 1 of the 3 patients developed a
chest infection which required battery removal and therefore
the patient was lost for the follow-up. Moreover, in the study
by Zhang et al. [17] 1 patient who underwent bilateral
subthalamic DBS for TD had transient laughter which may
indicate stimulation of other than sensorimotor subthalamic
subterritory. After reprogramming of stimulation settings the
stimulation-induced laughter in this patient disappeared.
In general, all infections healed after antibiotics making it
possible to implant new hardware. One misplaced lead was
successfully replaced. Only 2 patients gained partial beneﬁt
due to intracerebral hemorrhage. Also 2 patients in the report
by Krause gained no beneﬁt from GPi stimulation for unknown
reasons and their condition worsened over follow-up months.
The complication rate is then similar to other studies implying
GPi or STN DBS for dystonic conditions [2,3].
8. Non-motor effects of deep brain stimulation
in tardive dystonia patients
Although the patients with TD are mainly handicapped by
their motor disability and the associated reduced quality of
life, mood as well as psychosocial functions were observed to
change after surgery. In general, GPi DBS in Parkinson's
disease is regarded as a safe treatment regarding cognition but
some studies of GPi DBS in PD patients reported postoperative
impairments of executive functions, verbal ﬂuency and
memory [24]. These observations were not conﬁrmed in the
short report by Haelbig et al. [25]. These authors performed an
extensive assessment of cognitive and neuropsychiatric
functions using a battery of objective tests in 15 dystonic
patients including 2 patients with TD, thus demonstrating the
procedure's safety. The authors conclude that no deterioration
was observed in cognitive scores and neuropsychiatric
measures [25]. Moreover, two patients (one reported on by
Trottenberg et al. [6], and the other by Sako et al. [9]) showed
signiﬁcant mood improvement without objective measures
presented. Gruber et al. [10] were the ﬁrst to perform objective
assessment of mood and neuropsychological functions in 9
consecutive patients suffering from TD after bilateral GPi.
These authors showed improvement in mood scores with no
Table 3 – Stimulation settings in published articles reporting the results of bilateral GPi DBS for patients treated for tardive dystonia. The time to response as well adverse
events in each of the articles are presented. M, monopolar; B, Bipolar; pt, patient; pts, patients; NR, not reported.
Author Number of
patients
Mode Contacts Amplitude (V)
Mean
SD +/ range
Frequency (Hz)
Mean
SD +/ range
Pulse width
(us) Mean
SD +/ range
Response to
stimulation
Adverse events
Trottenberg
et al. [5] 2001
1 M NR 3.0 V 150 Hz 210 us A few hours No
Trottenberg
et al. [6] 2005
5 M One or two adjacent
cathods
2.7  0.8 V 144  22 Hz 111  57 Rapid response within
12 to 72 hours
No
Franzini
et al. [7] 2005
2 M Distal contact
cathod
1 V 130 90 Good response
within 3 days
No
Cohen
et al. [8] 2007
2 M Cathode contacts
1 and 5
4.0 V 130 Hz 90 in pt 1
120 in pt 2
A few hours No
Sato et al.
[9] 2008
6 One or two adjacent
Ventral cathodes
2.2  0.9 119  28 Hz 450 us Days to weeks No
Gruber et al.
[10] (2009)
9 M NR Right GPi 3.0  1.0
Left GPi 2.8  0.6 V
154 Hz  25.1 83.3  13.2 In 5 pts response within
minutes to hours, in
4 patients within weeks
to months
No
Capelle et al.
[11] 2010
4 3 pts B
1 pt M
Cathode contact
1 anode contact 2
4.5 V 130 Hz in 3 pts
160 Hz in 1 pt
210 in 3 pts
90 us in 1 pt
Response delayed due
to optimization of
stimulation settings
1 misplaced
lead–revision
1 case of IPG
depletion 16 months
Chang et al.
[12] 2010
5 M One or two adjacent
cathodes
NR Initial 145–185 Initial 210 us NA probably delayed Pt 4 infection 10 months
after routine IPG replacement
after 2 weeks of antibiotic
treatment
1 pt venous infarction
without behavioral and
mood changes
Shaikh et al.
[13] 2015
8 M NR 3.8  0.4 V 84.5  30.4 141.8  40.4 us Days to months No
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Table 4 – Stimulation settings in published articles reporting the results of bilateral GPi DBS for patients treated for various dystonia types. The time to response as well
adverse events in each of the articles are presented. M, monopolar; B, Bipolar; AEs, adverse events; NR, not reported; NS, not specifically reported for TD patients but for the
whole dystonia group; pt, patient; pts, patients.
Author Number of
patients
Mode Contacts Amplitude
(V) Mean
SD +/ range
Frequency
(Hz) Mean
SD +/range
Pulse width
(us) Mean
SD +/range
Response to
stimulation
Adverse events
Yianni et al. [15] 2003 1 pt among 25 B Deepest contact
cathode, superﬁcila
anode without AEs.
Initial stimulation
setting for all
4.0–7.0
130 Hz–180 Hz 150–240 us Hours to response No
Krause et al. [16] 2004 3 pts among 17 M Contacts above
evoking phosphenes
Initial stimulation
setting for all
V
130 Hz 210 us No improvement
Slight worsening
over follow-up
1 case of infection
removal of all
hardware.
Starr et al. [3] 2006 4 among 23 pts
with dystonia
Mostly
M
NS NR NR NR NR Multifocal left
frontal
hemorrhage–venous
infarction aphasia
and hemiparesis.
Full recovery but
dystonia not
responded to DBS.
Zhang et al. [17] 2006 2 pts among 9 NR NR NR NR NR Weeks to months 1 patient persistent
laughter
Sun et al. [18] 2007 2 pts among 12 pts B NR 2.0–3.0 V 135–185 Hz 90–120 us Immediate response No
Egidi et al. [19] 2007 5 pts among 69 NR NR NR 130 Hz 90–120 us Days to response No
Pretto et al. [20] 2008 1 pt among 13 pts NS NS 4.1 V 185 Hz 90 us NR No
Magarinos-Ascone
et al. [21] 2008
1 pt among 10 NS Lowest contacts 2.5  0.2 NS 135–160 NS 118.5 us for
all pts NS
NR No
Katsokiori et al. [22] 2009 1 pt among 8 M NR 2.5–4.5 V NS 185 Hz NS 210–450 us NS Weeks to months No
Kim et al. [23] 2011 1 pt among 10 M NR Initial stimulation
setting for all
V
88.7 Hz 165 us Hours to response No
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dency for improvement in verbal ﬂuency was observed as well
[10]. Unfortunately, no cognitive impairment was noted in any
of the reports describing GPi DBS for TD. To the best of our
knowledge there were no suicide attempts in TD patients after
DBS procedures. In contrast, in the report by Foncke et al. [26]
2 patients with preoperative periods of depression among
16 operated on for different forms of dystonia committed
suicide, 3 weeks and approximately 14 months after surgery.
These authors advocate extensive psychiatric and neuropsy-
chological evaluation both pre and postoperatively [26]. The
above-mentioned studies conﬁrm the safety of GPi DBS in TD
patients.
9. Possible therapeutic effects of deep brain
stimulation explained by functional imaging
studies
The mechanisms of action of GPi DBS in primary generalized
dystonia and especially in TD are complex and not fully
understood [27,28]. The GPi represents the major output
nucleus of the basal ganglia, which controls supplementary
motor cortex thought the ventrolateral thalamus and its
thalamocortical connections. The rationale for GPi DBS is
based on positive results of pallidotomy and subsequently
pallidal stimulation for dystonic symptoms seen in patients
with Parkinson's disease.
The pathophysiology of TD is still discussed, but the main
hypothesis is that neuroleptic agents induce supersensitiza-
tion of dopaminergic D1 receptors by endogenous dopamine,
with subsequent neuroleptic-induced blockage of presynaptic
D2 receptors causing a dysfunction of direct and indirect
pathways [29,30]. This dysfunction increases D1 mediated
(direct pathway) striatal output which inhibits the GPi,
releasing the glumaminergic thalamocortical connections,
leading to an excess of brain activation observed in different
dystonia types including TD.
The results of functional imaging studies have shed some
light on the pathophysiology of primary generalized dystonia
and on TD as well [31,32]. These functional imaging studies
revealed generally widespread brain activation to a simple
motor task, a loss of cortico-cortocal inhibition, and a lack of
selectivity of brain activation in dystonic patients [33]. In
addition to these ﬁndings, the dysfunction of the cortical
sensory system with enhanced response of the basal ganglia to
sensory inputs has been shown [34]. All above-mentioned
patterns of brain activation in primary generalized dystonia
patients can be efﬁciently reversed by pallidal stimulation [31].
TD usually does not differ clinically from focal, segmental or
primary generalized dystonia. The same patterns of brain
activation changes due to GPi DBS in TD patients was proven in
the report by Thobois et al. [31] using Positron Emission
Tomography (PET) in 5 patients. The authors have shown that
TD is related to an excess of brain activation in prefrontal brain
areas. The GPI DBS in TD visibly reduces the activation of
motor, premotor, prefrontal cortex as well as activation of
cerebellum. In another report by Katsakiori et al. [22] the
authors report on 8 patients with various secondary dystonia
types including 1 patient with TD, who underwent a SinglePhoton Emission Computed Tomography (SPECT). The authors
have shown widespread decrease of brain activation in
response to bilateral GPI DBS. In conclusion, reducing or
replacement of abnormal patterns of neuronal activity seen in
GPi by DBS may normalize the thalamocortical pathways and
adjust the abnormal cortical hypermetabolism in widespread
motor cortical areas [35].
10. Conclusion
The rapid and long-term improvement in TD patients supports
the observation that DBS is a promising treatment for patients
affected by disabling TD unresponsive to pharmacological
therapies and botulinum toxin injections. The safety proﬁle
and efﬁcacy of bilateral GPi stimulation constitutes a valuable
treatment solution for patients handicapped by intractable TD.
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